Drugs / AMG 378
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06910709 | Apr → Dec 2025 | — | Amgen | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 378 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06910709 ↗ |
| Route | Oral | “Oral tablet” NCT06910709 ↗ |